Early combination therapy with a thiazolidinedione for the treatment of type 2 diabetes.
Kanzer-Lewis
Ginger
G
gingerk@csi.com
D002318:Cardiovascular Diseases / Q000209:etiology; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D018450:Disease Progression; D004359:Drug Therapy, Combination; D006442:Glycated Hemoglobin / Q000187:drug effects; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D007333:Insulin Resistance; D024821:Metabolic Syndrome / Q000150:complications; D024802:Nurse's Role; D009765:Obesity / Q000150:complications; D010353:Patient Education as Topic / Q000379:methods; D012307:Risk Factors; D045162:Thiazolidinediones / Q000494:pharmacology / Q000627:therapeutic use*
D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D045162:Thiazolidinediones